Last reviewed · How we verify
adequate mood stabilizer
This drug stabilizes mood by modulating neurotransmitter activity.
This drug stabilizes mood by modulating neurotransmitter activity. Used for Bipolar disorder, Major depressive disorder.
At a glance
| Generic name | adequate mood stabilizer |
|---|---|
| Sponsor | AstraZeneca |
| Drug class | Mood stabilizer |
| Modality | Small molecule |
| Therapeutic area | Psychiatry |
| Phase | Phase 3 |
Mechanism of action
It achieves this by influencing the levels and activity of neurotransmitters such as serotonin and dopamine, which play a crucial role in regulating mood. This process helps to reduce the severity of mood swings and stabilize mood.
Approved indications
- Bipolar disorder
- Major depressive disorder
Common side effects
- Weight gain
- Dizziness
- Headache
- Nausea
- Diarrhea
Key clinical trials
- Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder (NA)
- Open Label Extension Study of NCT06221852 (NA)
- Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |